1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow BAX 855: new trials by email Literature Review of BAX 855 trials Research Report on BAX 855
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies Eloctate, Adynovate, Emicizumab - Hemophilia A, Factor VIII | Phase 4 | Withdrawn | University of Texas Southwestern Medical Center | 2021-04-15 | 2026-04-07 |
Hemophilia A (1)
University of Texas Southwestern Medical Center (1)
United States (1)